Our attorneys and consultants counsel U.S. and international research institutions and organizations on strategies to develop new technologies and bring innovation to industry, health systems and, most importantly, patients. We bring expertise in driving cross-sector collaborations among academic institutions, government agencies, industry and nonprofit patient organizations. We help clients gain federal tax exemptions, make strategic changes to their clinical trial processes and contracting, and conduct evidence-based advocacy to enhance federal support for areas of distinction within the institution. We are recognized for our leadership in areas of rare disease, pediatrics and Alzheimer’s as stakeholders in these areas work to advance the development of treatments and medications that address some of today’s most pressing, unmet needs.

Related Services and Industries

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.